By Michael PricePubMed, the massive database of biomedical literature maintained by the U.S. National Center for Biotechnology Information (NCBI), is one of the U.S.
government’s most popular websites, with some 2 million users daily. So when something at PubMed changes, it doesn’t go unnoticed.Unfortunately for the site’s caretakers, however, a sweeping redesign unveiled this week has left many PubMed users fuming—and airing their sometimes curse-laden complaints on social media.“Am I the only one who hates the new PubMed?” tweeted @LCneuroscience, the laboratory of David Weinshenker, a geneticist at the Emory University School of Medicine, on 19 May, the day after NCBI rolled out its remake.“No.